Bondi Alessandro, Koumantakis Emanuele, Curtoni Antonio, Barbui Anna Maria, Peradotto Marco, Lombardi Daniela, Casale Roberto, Alizzi Silvia, Zanotto Elisa, Charrier Lorena, Cavallo Rossana, Costa Cristina
Microbiology and Virology Unit, AOU Città della Salute e della Scienza di Torino, 10126 Turin, Italy.
Department of Public Health and Pediatrics, University of Turin, 10126 Turin, Italy.
Antibiotics (Basel). 2024 Aug 6;13(8):740. doi: 10.3390/antibiotics13080740.
The international surveillance of antimicrobial resistance (AMR) reports as one of leading causes of death associated with AMR. Against invasive disease, several vaccinations are available and a reduction in AMR in has been observed. Here, we evaluated the impact of anti-pneumococcal vaccination policy and the SARS-CoV2 outbreak on AMR in causing invasive disease.
We collected all strains of causing invasive disease from 2008 in the Piedmont region (Italy). Each strain was typed in order to identify the serogroup and data about AMR were collected. The population under surveillance was classified as infants, children, adults, and the old population.
We collected = 2076 strains, with 21.9% and 40.3% being resistant to penicillin G and erythromycin, respectively. We reported an increased risk of infection with penicillin-resistant among all populations and evaluated whether the infection was caused by a serotype included in the vaccine formulation. A similar increase was observed after the SARS-CoV2 outbreak.
In the Piedmont region, subsequently to the introduction of anti-pneumococcal vaccination, a significant increase in the risk of penicillin G-resistant invasive pneumococcal disease among infants and old population was reported. No significant impact was found for the SARS-CoV2 outbreak.
国际抗菌药物耐药性监测报告称,抗菌药物耐药性是导致死亡的主要原因之一。针对侵袭性疾病,有几种疫苗可供使用,并且已观察到某地区抗菌药物耐药性有所降低。在此,我们评估了抗肺炎球菌疫苗接种政策和新冠疫情对某地区引起侵袭性疾病的抗菌药物耐药性的影响。
我们收集了2008年以来意大利皮埃蒙特地区所有引起侵袭性疾病的菌株。对每个菌株进行分型以确定血清群,并收集有关抗菌药物耐药性的数据。受监测人群分为婴儿、儿童、成年人和老年人群。
我们收集了n = 2076株菌株,分别有21.9%和40.3%对青霉素G和红霉素耐药。我们报告了所有人群中感染耐青霉素肺炎球菌的风险增加,并评估了感染是否由疫苗配方中包含的血清型引起。在新冠疫情爆发后也观察到了类似的增加。
在皮埃蒙特地区,引入抗肺炎球菌疫苗接种后,报告称婴儿和老年人群中耐青霉素G侵袭性肺炎球菌疾病的风险显著增加。未发现新冠疫情有显著影响。